FRLN Share Price Performance
US$0
0.00 (0.00%)
Price US$0
Share Pricen/a
Freeline Therapeutics Holdings plc Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
FRLN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Freeline Therapeutics Holdings plc Key Details
Last Reported Earnings
Sep 30, 2023
Next Reporting Earnings
n/a
- -11.45
- 100.00%
- -8,027.65%
- 0%
About FRLN
- Founded
- 2015
- Employees
- 152
- CEO
- WebsiteView website
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies. It develops FLT180a for the treatment of hemophilia B.; FLT201 for the treatment of Type 1 Gaucher disease; and FLT190 for the treatment of Fabry disease. in addition, it has research programs for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.
